GlyTherix and GEMINI Collaborate on Esophageal Cancer

GlyTherix and GEMINI Collaborate on Esophageal Cancer

Date, July 8 2022: Sydney. GlyTherix has commenced an exciting new collaboration with the GastroEsophageal Malignancies Investigator Network Initiative (GEMINI) to test its Miltuximab® monoclonal antibody therapies in gastroesophageal cancers. GEMINI, backed by the...
Carina Biotech and GlyTherix enter into CAR-T partnership

Carina Biotech and GlyTherix enter into CAR-T partnership

PRESS RELEASE September 10, 2020 Adelaide, Australia and Sydney, Australia. CAR-T biotherapeutics company Carina Biotech and immuno-oncology company GlyTherix are pleased to announce a co-development agreement that could result in a promising new CAR-T therapy that is...